HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].

AbstractOBJECTIVE:
To evaluate the efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm (GTN) patients, and investigate factors influencing the outcome of the surgery combined with chemotherapy.
METHODS:
Medical records of 42 patents with drug-resistant GTN who were treated by chemotherapy combined with surgical management at Peking Union Medical College Hospital from Jan 1996 to Jan 2006 were reviewed.
RESULTS:
Among 42 patients, 32 achieved serologically complete remission (SCR) with an SCR rate of 76%, and 10 patients had a treatment failure. Treatment failure was more frequently seen in patients who also had metastasis of other sites except for lungs and vagina and patients with antecedent non-molar pregnancy (P = 0.023 and 0.017, respectively). Preoperative human chorionic gonadotropin-beta subunit (beta-hCG) titer > 10 U/L (P = 0.020), failure to reach normal serum titers of beta-hCG during treatment (P = 0.003), age > or = 35 years (OR: 12.6, 95% CI: 2.4 - 66.0, P = 0.002) and preoperative chemotherapy regimens > or = 4 (OR: 4.5, 95% CI: 1.0 - 20.1, P = 0.059) were also correlated with treatment failure. All the 10 patients with treatment failure had at least 3 of 6 above mentioned predictors of treatment failure.
CONCLUSIONS:
Surgical management combined with chemotherapy is effective in the treatment of drug-resistant GTN. Age > or = 35 years, antecedent non-molar pregnancy, metastasis of other sites except for lungs and vagina, preoperative beta-hCG titer > 10 U/L, failure to reach normal serum titers of beta-hCG during treatment, and preoperative chemotherapy regimens > or = 4 are significant predictors of treatment failure. Patients with 3 or more predictors of treatment failure usually have poor prognosis. Therefore, surgical management should not be performed for these patients.
AuthorsFeng-Zhi Feng, Yang Xiang, Yang Cao, Lei Li, Xi-Run Wan, Xiu-Yu Yang
JournalZhonghua fu chan ke za zhi (Zhonghua Fu Chan Ke Za Zhi) Vol. 43 Issue 10 Pg. 728-31 (Oct 2008) ISSN: 0529-567X [Print] China
PMID19087536 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Chorionic Gonadotropin, beta Subunit, Human
  • Dactinomycin
  • Etoposide
  • Fluorouracil
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chorionic Gonadotropin, beta Subunit, Human (blood)
  • Combined Modality Therapy
  • Dactinomycin (administration & dosage)
  • Drug Resistance, Neoplasm
  • Etoposide (administration & dosage)
  • Female
  • Fluorouracil (administration & dosage)
  • Gestational Trophoblastic Disease (drug therapy, pathology, surgery)
  • Humans
  • Hysterectomy
  • Lung Neoplasms (secondary, surgery)
  • Middle Aged
  • Neoplasm Staging
  • Pregnancy
  • Retrospective Studies
  • Treatment Outcome
  • Uterine Neoplasms (drug therapy, pathology, surgery)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: